Business StandardCenter·
Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA
Concord Biotech shares jumped 5.8 per cent on BSE after USFDA cleared Tofacitinib Tablets ANDA
Read at Business Standard →
Business · 1 sources covering this
Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA
Concord Biotech shares jumped 5.8 per cent on BSE after USFDA cleared Tofacitinib Tablets ANDA
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/284575e2f886c6a7039651d8fbfc8a9d026e4f29" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Concord Biotech share rises 6% after USFDA clears Tofacitinib Tablets ANDA"></iframe>
